IP Library Granted Patent US 9,180,090
Granted Patent B2
US 9,180,090 · App. 13/644,290 · Granted Nov 10, 2015

Non-sedating antihistamine injection formulations and methods of use thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,180,090
App. No.
13/644,290
Granted
Nov 10, 2015
Kind
B2
Abstract

Disclosed are injectable formulations of cetirizine for treating acute allergic reactions and methods for treating acute allergic reactions. In particular, an intravenous injectable is disclosed as are methods of treating acute allergic reactions.

Claims (8)

1. A method of treating a patient, comprising

administering to the patient an injectable formulation comprising 1 to 10 mg/mL of cetirizine or levocetirizine, or a pharmaceutically acceptable salt, or polymorph of the cetirizine or levocetirizine,

wherein the injectable formulation is free of hemolysis when contacted with a human blood sample, and

wherein the patient is in need of treatment for an acute allergic reaction.

2. The method of claim 1 , wherein the acute allergic reaction is an allergic condition of the immediate type.

3. The method of claim 1 , wherein the acute allergic reaction is anaphylaxis.

4. The method of claim 1 , wherein the acute allergic reaction is a severe allergic reaction to blood or plasma, food, medication, or an allergy-inducing material.

5. The method of claim 1 , wherein treating is in an emergency situation.

Assignments (9)
RELEASE OF INTELLECTUAL PROPERTY SECURITY AGREEMENTS AT R/F 63216/0020 Recorded May 13, 2026
From: ANTARES CAPITAL LP
To: JDP THERAPEUTICS LLC
Reel/Frame 075572/0854 →
RELEASE OF SECOND LIEN PATENT SECURITY AGREEMENT RECORDED AT R/F 063227/0713 Recorded Jan 8, 2025
From: NEWSTONE CAPITAL PARTNERS, LLC
To: JDP THERAPEUTICS LLC
Reel/Frame 069840/0419 →
SECURITY INTEREST Recorded Apr 5, 2023
From: JDP THERAPEUTICS LLC
To: NEWSTONE CAPITAL PARTNERS, LLC
Reel/Frame 063227/0713 →
SECURITY INTEREST Recorded Apr 4, 2023
From: JDP THERAPEUTICS LLC
To: ANTARES CAPITAL LP, AS AGENT
Reel/Frame 063216/0020 →
RELEASE OF SECURITY INTEREST Recorded Apr 4, 2023
From: NEWSTONE CAPITAL PARTNERS, LLC
To: TERSERA THERAPEUTICS LLC; JDP THERAPEUTICS LLC
Reel/Frame 063221/0546 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 2, 2019
From: DU, JIE
To: JDP THERAPEUTICS, INC.
Reel/Frame 049655/0541 →
SECURITY INTEREST Recorded May 13, 2019
From: JDP THERAPEUTICS LLC
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 049157/0360 →
SECURITY INTEREST Recorded May 10, 2019
From: JDP THERAPEUTICS LLC
To: NEWSTONE CAPITAL PARTNERS, LLC
Reel/Frame 049143/0782 →
ENTITY CONVERSION Recorded Apr 30, 2019
From: JDP THERAPEUTICS, INC.
To: JDP THERAPEUTICS LLC
Reel/Frame 049042/0187 →